American International Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,825
| Closed | -$97.3K | – | 1527 |
|
|
2024
Q1 | $97.3K | Buy |
12,825
+77
| +0.6% | +$584 | ﹤0.01% | 2534 |
|
|
2023
Q4 | $58K | Sell |
12,748
-51
| -0.4% | -$232 | ﹤0.01% | 2783 |
|
|
2023
Q3 | $50.6K | Buy |
12,799
+454
| +4% | +$1.79K | ﹤0.01% | 2813 |
|
|
2023
Q2 | $38.6K | Buy |
+12,345
| New | +$38.6K | ﹤0.01% | 2937 |
|
|
2019
Q2 | – | Sell |
-1,620
| Closed | -$53K | – | 3137 |
|
|
2019
Q1 | $53K | Sell |
1,620
-52
| -3% | -$1.7K | ﹤0.01% | 2855 |
|
|
2018
Q4 | $99K | Sell |
1,672
-13
| -0.8% | -$770 | ﹤0.01% | 2596 |
|
|
2018
Q3 | $236K | Buy |
1,685
+446
| +36% | +$62.5K | ﹤0.01% | 2331 |
|
|
2018
Q2 | $152K | Buy |
+1,239
| New | +$152K | ﹤0.01% | 2531 |
|
|
2017
Q2 | – | Sell |
-1,173
| Closed | -$66K | – | 3102 |
|
|
2017
Q1 | $66K | Buy |
1,173
+78
| +7% | +$4.39K | ﹤0.01% | 2760 |
|
|
2016
Q4 | $42K | Sell |
1,095
-3
| -0.3% | -$115 | ﹤0.01% | 2893 |
|
|
2016
Q3 | $43.6K | Buy |
1,098
+2
| +0.2% | +$79 | ﹤0.01% | 2925 |
|
|
2016
Q2 | $78.8K | Buy |
1,096
+291
| +36% | +$20.9K | ﹤0.01% | 2769 |
|
|
2016
Q1 | $64K | Hold |
805
| – | – | ﹤0.01% | 3727 |
|
|
2015
Q4 | $61K | Sell |
805
-1
| -0.1% | -$76 | ﹤0.01% | 3797 |
|
|
2015
Q3 | $309K | Buy |
806
+1
| +0.1% | +$383 | ﹤0.01% | 2420 |
|
|
2015
Q2 | $335K | Buy |
805
+443
| +122% | +$184K | ﹤0.01% | 2544 |
|
|
2015
Q1 | $172K | Hold |
362
| – | – | ﹤0.01% | 3092 |
|
|
2014
Q4 | $134K | Buy |
+362
| New | +$134K | ﹤0.01% | 3315 |
|